Yutaka Niihara - Sep 26, 2022 Form 4 Insider Report for Emmaus Life Sciences, Inc. (EMMA)

Role
Chairman and CEO, Director, 10%+ Owner
Signature
Yutaka Niihara, M.D., M.P.H.
Stock symbol
EMMA
Transactions as of
Sep 26, 2022
Transactions value $
$20,370
Form type
4
Date filed
10/12/2022, 01:04 PM
Previous filing
Jun 2, 2022
Next filing
Oct 13, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EMMA Common stock, $0.001 par value Purchase $1.2K +6K +0.05% $0.20 11.3M Sep 26, 2022 Direct F1
transaction EMMA Common stock, $0.001 par value Purchase $1K +5K +0.04% $0.20 11.3M Sep 27, 2022 Direct F1
transaction EMMA Common stock, $0.001 par value Purchase $2K +10K +0.09% $0.20 11.4M Oct 3, 2022 Direct F1
transaction EMMA Common stock, $0.001 par value Purchase $800 +5K +0.04% $0.16 11.4M Oct 4, 2022 Direct F1
transaction EMMA Common stock, $0.001 par value Purchase $1.5K +10K +0.09% $0.15 11.4M Oct 5, 2022 Direct F1
transaction EMMA Common stock, $0.001 par value Purchase $750 +5K +0.04% $0.15 11.4M Oct 6, 2022 Direct F1
transaction EMMA Common stock, $0.001 par value Purchase $520 +4K +0.04% $0.13 11.4M Oct 7, 2022 Direct F1
transaction EMMA Common stock, $0.001 par value Purchase $900 +10K +0.09% $0.09 11.4M Oct 10, 2022 Direct F1
transaction EMMA Common stock, $0.001 par value Purchase $11.7K +130K +1.14% $0.09 11.5M Oct 11, 2022 Direct F1, F2
holding EMMA Common stock, $0.001 par value 92.8K Sep 26, 2022 By Hope International Hospice, Inc. F3
holding EMMA Common stock, $0.001 par value 63K Sep 26, 2022 By Soomi Niihara
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.
F2 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.08 to $0.12, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2).
F3 Hope International Hospice, Inc. is a California corporation of which Dr. Niihara and his wife are the sole shareholders and directors.